GNOM.L vs. IHCU.L
GNOM.L (Global X Genomics & Biotechnology UCITS ETF) and IHCU.L (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) are both Health & Biotech Equities funds - GNOM.L tracks the Global X Genomics & Biotechnology UCITS ETF while IHCU.L tracks the iShares S&P 500 Health Care Sector UCITS ETF USD (Acc). Both are passively managed. Over the past 3 years, GNOM.L returned 4.58%/yr vs 8.23%/yr for IHCU.L. At a 0.44 correlation, their price movements are largely independent. GNOM.L charges 0.50%/yr vs 0.15%/yr for IHCU.L.
Performance
GNOM.L vs. IHCU.L - Performance Comparison
Loading charts...
Different Trading Currencies
GNOM.L is traded in USD, while IHCU.L is traded in GBp. To make them comparable, the IHCU.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, GNOM.L achieves a 22.10% return, which is significantly higher than IHCU.L's 3.24% return.
GNOM.L
- 1D
- -0.17%
- 1M
- 11.69%
- 6M
- 15.71%
- YTD
- 22.10%
- 1Y
- 62.79%
- 3Y*
- 4.58%
- 5Y*
- —
- 10Y*
- —
IHCU.L
- 1D
- 0.00%
- 1M
- 4.56%
- 6M
- 2.21%
- YTD
- 3.24%
- 1Y
- 21.72%
- 3Y*
- 8.23%
- 5Y*
- 5.83%
- 10Y*
- 9.54%
GNOM.L vs. IHCU.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 22.10% | 19.30% | -17.99% | -5.77% | -37.21% | -8.59% |
IHCU.L iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) | 3.24% | 14.83% | 2.22% | 1.18% | -2.66% | 6.69% |
Correlation
The correlation between GNOM.L and IHCU.L is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Nov 2, 2021 | 0.44 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM.L vs. IHCU.L — Risk / Return Rank
GNOM.L
IHCU.L
GNOM.L vs. IHCU.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GNOM.L) and iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IHCU.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GNOM.L | IHCU.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.72 | ||
| Sortino ratioReturn per unit of downside risk | +0.80 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.24 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 3.35 | 2.00 | +1.34 |
| Martin ratioReturn relative to average drawdown | 9.16 | 4.97 | +4.20 |
Loading charts...
Drawdowns
GNOM.L vs. IHCU.L - Drawdown Comparison
The maximum GNOM.L drawdown since its inception was -69.32%, which is greater than IHCU.L's maximum drawdown of -41.33%. Use the drawdown chart below to compare losses from any high point for GNOM.L and IHCU.L.
Loading charts...
Drawdown Indicators
| GNOM.L | IHCU.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.32% | -41.33% | -27.99% |
Max Drawdown (1Y)Largest decline over 1 year | -18.91% | -10.55% | -8.36% |
Max Drawdown (3Y)Largest decline over 3 years | -44.77% | -19.50% | -25.27% |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.50% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -27.15% | — |
Current DrawdownCurrent decline from peak | -37.11% | -3.08% | -34.03% |
Average DrawdownAverage peak-to-trough decline | -47.16% | -12.57% | -34.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.92% | 4.27% | +2.65% |
Volatility
GNOM.L vs. IHCU.L - Volatility Comparison
Global X Genomics & Biotechnology UCITS ETF (GNOM.L) has a higher volatility of 8.41% compared to iShares S&P 500 Health Care Sector UCITS ETF USD (Acc) (IHCU.L) at 5.42%. This indicates that GNOM.L's price experiences larger fluctuations and is considered to be riskier than IHCU.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM.L | IHCU.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 5.42% | +2.99% |
Volatility (6M)Calculated over the trailing 6-month period | 22.18% | 11.35% | +10.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.87% | 15.09% | +14.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.11% | 20.58% | +12.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.11% | 18.62% | +14.49% |
GNOM.L vs. IHCU.L - Expense Ratio Comparison
GNOM.L has a 0.50% expense ratio, which is higher than IHCU.L's 0.15% expense ratio.
Dividends
GNOM.L vs. IHCU.L - Dividend Comparison
Neither GNOM.L nor IHCU.L has paid dividends to shareholders.
Frequently Asked Questions
GNOM.L and IHCU.L have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IHCU.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IHCU.L is cheaper with a 0.15% expense ratio, compared with 0.50% for GNOM.L.
GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF, while IHCU.L tracks iShares S&P 500 Health Care Sector UCITS ETF USD (Acc). They also come from different issuers: Global X and iShares. Their fees differ too: 0.50% for GNOM.L and 0.15% for IHCU.L.
Find the right allocation for GNOM.L and IHCU.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer